CVS Health Corporation
CVS
$65.75
$0.911.40%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.65% | 6.02% | 2.47% | 3.58% | 12.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.65% | 6.02% | 2.47% | 3.58% | 12.00% |
| Cost of Revenue | 6.10% | 8.77% | 3.36% | 5.53% | 14.22% |
| Gross Profit | -10.76% | -9.71% | -2.55% | -7.16% | 0.53% |
| SG&A Expenses | 0.76% | 7.50% | 5.47% | 7.27% | 3.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.49% | 8.63% | 3.60% | 5.73% | 12.93% |
| Operating Income | -44.82% | -57.59% | -24.03% | -46.43% | -7.95% |
| Income Before Tax | -21.40% | -96.52% | -9.07% | -45.12% | -14.13% |
| Income Tax Expenses | -23.56% | -95.49% | -13.26% | -38.13% | -19.56% |
| Earnings from Continuing Operations | -20.71% | -96.87% | -7.63% | -47.53% | -12.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2,200.00% | 500.00% | 115.38% | -83.33% | -150.00% |
| Net Income | -19.65% | -96.15% | -6.89% | -47.89% | -12.34% |
| EBIT | -44.82% | -57.59% | -24.03% | -46.43% | -7.95% |
| EBITDA | -33.42% | -42.88% | -17.43% | -33.07% | -4.31% |
| EPS Basic | -17.80% | -96.07% | -4.89% | -46.94% | -10.84% |
| Normalized Basic EPS | -35.73% | -56.04% | -22.36% | -49.35% | -11.49% |
| EPS Diluted | -17.80% | -96.05% | -4.78% | -46.67% | -10.47% |
| Normalized Diluted EPS | -35.58% | -55.94% | -22.30% | -49.31% | -11.23% |
| Average Basic Shares Outstanding | -2.25% | -2.18% | -2.10% | -1.79% | -1.68% |
| Average Diluted Shares Outstanding | -2.47% | -2.40% | -2.18% | -1.86% | -1.97% |
| Dividend Per Share | 9.92% | 9.92% | 9.92% | 9.92% | 10.00% |
| Payout Ratio | 0.34% | 26.92% | 0.16% | 1.07% | 0.24% |
